Zhejiang Hisoar Pharmaceutical Co., Ltd. ( China (Mainland))

Hisoar, established in 1966, specializes in the production and distribution of the crude drug and medicine intermediate. It is located in Taizhou of Zhejiang province. In 2006, its turnover reached 770 million yuan, and 70% of the products were exported to overseas. 

Hisoar built up ISO9002 system in 1997, got ISO9001 (2000 version) certificate since 2001, got GMP certificate from SDA in 2002, obtained ISO14001 in March 2003, pass US FDA and are granted European COS for Clindamycin in 2004. Five API were approved by SFDA and got the GMP Certificates in Jan 2005. For some other single country, Hisoar have got DMF registration.

The main APIs products are antibiotics, anti-disabets, anti-infective, anti-hepatitis, disuresis, diminish inflammation, anti-blues and anti-AIDS ,which are used for human or animal. The fine chemicals include pharmaceutiical intermediates, pesticide intermediates and other products. Some product include AOSA (76855-69-1), 2,3,3,3-Tetrafluoropropanoic acid (359-49-9), 1,1-Dimethylcysteamine HCl (101312-92-9), 2,4,5-trifluorophenylacetic acid (209995-38-0), Protected Meropenem (96036-02-1), etc.